Information  X 
Enter a valid email address

JPMorgan Amer InvTst (JAM)


Tuesday 04 January, 2022

JPMorgan Amer InvTst

Closed Period Notification

RNS Number : 4206X
JPMorgan American IT PLC
04 January 2022


(the 'Company')


Compliance with Market Abuse Regulation


Closed Period Notification


Legal Entity Identifier: 549300QNAI4XRPEB4G65

Information disclosed in accordance with Market Abuse Regulation Article 19, paragraph 11


The Company announces that it is satisfied that all inside information which the Directors and the Company may have in the period leading up to the announcement of its results for the year ended 31st December 2021 has previously been, and will continue to be, notified to the London Stock Exchange ('LSE') via a regulatory information service. Therefore, the Company is not prohibited from dealing in its own securities.


The mandatory closed period under Market Abuse Regulation will commence on 15th February 2022 and will last until the results in respect of the year ended 31st December 2021 are published on or around 1st April 2022.  


If in the period leading up to the announcement of the year end results,   the Directors of the Company come into the possession of any inside information, this will be notified to the LSE  before any such transactions are undertaken.



4th January 2022



For further information, please contact:


Priyanka Vijay Anand


JPMorgan Funds Limited - Company Secretary


020 7742 4000


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t